·Clinical Research· Current
Issue IF in JCR CiteScore ·Submission· In Press Recent Accepted PMC RSS
Citation: Ren MW, Du Y, Ren S, Tang CY, He JF. Epstein-Barr
virus-encoded small RNAs in idiopathic orbital inflammatory pseudotumor
tissues: a comparative case series. Int J Ophthalmol 2017;10(8): 1268-1272
Epstein-Barr virus-encoded small RNAs in
idiopathic orbital inflammatory pseudotumor tissues: a comparative case series
Min-Wei Ren1,2, Yi Du1, Shan
Ren2, Cheng-Ye Tang1, Jian-Feng He1
1Department of Ophthalmology, the First Affiliated Hospital of
Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region,
China
2Department of Ophthalmology, Liuzhou People's Hospital, Liuzhou
545006, Guangxi Zhuang Autonomous Region, China
Co-first
authors: Min-Wei Ren and Yi Du
Correspondence
to: Jian-Feng He. Department of Ophthalmology, the First Affiliated
Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning 530021,
Guangxi Zhuang Autonomous Region, China. hejianf@foxmail.com
Received:
2016-09-17
Accepted: 2017-05-24
AIM: To
investigate the positive rate and types of cells that express Epstein-Barr
virus-encoded small RNAs (EBERs) and to determine the distribution of
EBER-expressing cells in idiopathic orbital inflammatory pseudotumor (IOIP)
tissues.
METHODS:
We retrospectively examined 40 archived paraffin specimens from two teaching
hospitals in Southern China between January 2007 and January 2015 that were
pathologically determined to exhibit IOIP. Eleven concurrent paraffin specimens
of thyroid-associated ophthalmopathy (TAO) composed the control group. In
situ hybridization was performed to detect EBERs. Immunohistochemistry was
employed to detect CD3, CD20, Vimentin, and smooth muscle actin (SMA), and the
positive rate, types of positive cells, and distribution and location of EBERs
were evaluated.
RESULTS: The
positive expression rate of EBERs was 47.5% (19/40) in the IOIP group, which
was significantly higher than that in the TAO group [0 (0/11), P=0.011].
In the IOIP group, the lymphocyte infiltrative subtype, fibrotic subtype, and
mixed subtype exhibited EBER-positive rates of 57.1% (12/21), 12.5% (1/8), and
54.5% (6/11), respectively, and no significant differences were found between
these subtypes (P=0.085). Positive signals of EBERs were mainly present
in medium-small lymphocytes between or around follicles and in the nuclei of
activated immunoblasts (14/19).
CONCLUSION: The
positive rate, types, and distribution of EBER-expressing cells in IOIP have
been documented. These findings are conducive for a better understanding of the
underlying mechanisms of Epstein-Barr virus infection in IOIP pathogenesis.
KEYWORDS:
Epstein-Barr virus; Epstein-Barr virus-encoded small RNAs; thyroid
eye disease; Graves’ ophthalmopathy; idiopathic orbital inflammatory disease
DOI:10.18240/ijo.2017.08.14
Citation: Ren MW, Du Y, Ren S, Tang CY, He JF. Epstein-Barr virus-encoded small
RNAs in idiopathic orbital inflammatory pseudotumor tissues: a comparative case
series. Int J Ophthalmol
2017;10(8): 1268-1272
Idiopathic
orbital inflammatory pseudotumor (IOIP), also known as orbital pseudotumor, was
first described by Birech-Hirsechfeld in 1905 as an intra-orbital inflammatory process
that was non-specific and non-neoplastic[1-6].
Currently, the underlying pathological mechanisms of IOIP have yet to be fully
understood[7-8]. Pender proposed
that infection by Epstein-Barr virus (EBV) might be a trigger for multiple
chronic autoimmune diseases[9-10].
Jin et al[11] found that the positive rate
of EBV DNA in the plasma samples of IOIP patients was three times as much as
control group. Nevertheless, the types of cells and their distribution and
specific locations in IOIP tissues are not fully understood.
Epstein-Barr
virus-encoded small RNAs (EBERs) are the most abundant viral transcripts in
cells with latent EBV infection[12]. EBER
detection using in situ hybridization is considered the gold standard
for determining and locating latent EBV infection[12].
It has been demonstrated that persistent transcription of EBERs occurs in
almost every EBV-associated lesion[13]. The goal
of this study is to examine the EBER-positive rate, types of EBER-positive
cells, and the distribution of EBER-positive cells in IOIP tissues.
Ethics
Statement This
retrospective study was approved by the institutional review board of the First
Affiliated Hospital of Guangxi Medical University and followed the tenets of
the Declaration of Helsinki. Written informed consent was provided by all study
participants or their legal guardians.
Clinical
Samples The archived
paraffin specimens of 40 continuous IOIP cases, which were pathologically
determined between January 2007 and January 2015 at the First Affiliated
Hospital of Guangxi Medical University and Liuzhou People's Hospital, were used
as the case group. In addition, the paraffin specimens of 11 patients with
thyroid-associated ophthalmopathy (TAO) who underwent orbital decompression or
strabismus surgery during the same period composed the control group.
Pathological classification of IOIP was based on the method of Henderson[14], and inflammatory pseudotumor tissues were classified
into three subtypes: lymphocyte infiltrative subtype, fibrotic subtype, and
mixed subtype. The diagnostic criteria of TAO were based on those of Bartley
and Gorman[15]. All specimens were fixed with 10%
neutral formalin and then sliced into 4-μm paraffin-embedded sections. All
tissue sections were subjected to hematoxylin-eosin and immunohistochemical
staining for pathological confirmation. In addition, each paraffin-embedded
specimen was used to generate five continuous sections, which were used for in
situ hybridization of EBERs as well as for immunohistochemical staining of
CD3, CD20, Vimentin, and SMA.
In situ Hybridization of Epstein-Barr virus-encoded
small RNAs REMBRANDT®
in situ Hybridisation and Detection Kits (PanPath, Netherlands) were
used to detect EBERs, and digoxin-labeled oligonucleotide probes were used to
detect EBER1 and EBER2 according to the manufacturer’s instructions.
Immunohistochemical
Staining of CD3, CD20, Vimentin and SMA
Monoclonal antibodies against CD3, CD20, SMA, and Vimentin and the
GTVisionTM Secondary Antibody Kit (GeneTech, Shanghai, China) were used for
immunohistochemical staining according to the manufacturers’ instructions.
Statistical
Analysis SPSS 13.0
software was used for statistical analyses. Chi-square tests were used to
compare the count data between groups. Independent samples t-test were
used to compare the age between groups. A value of P<0.05 was
considered statistically significant.
Epstein-Barr
Virus-encoded Small RNA Expression in Idiopathic Orbital Inflammatory
Pseudotumor and Thyroid-associated Ophthalmopathy The positive
EBER expression of IOIP group was significantly higher than that of TAO group
(47.5% vs 0, P=0.011) (Table 1). In IOIP group, the lymphocyte
infiltrative subtype, fibrotic subtype, and mixed subtype had EBER-positive
rates of 57.1% (12/21), 12.5% (1/8) and 54.5% (6/11), respectively, which were
not significantly different (P=0.085).
Table
1 The clinical features and EBERs expression in IOIP and TAO groups n (%)
Characteristics |
IOIP group (n=40) |
TAO group (n=11) |
P |
Gender |
|
|
0.0181 |
Male |
18 (45) |
10 (90.9) |
|
Female |
22 (55) |
1 (9.1) |
|
Age (a) |
49.1±20.2 |
39.3±13.8 |
0.1362 |
Unilateral
or bilateral involvement |
|
<0.0011 |
|
Unilateral |
35 (87.5) |
1 (9.1) |
|
Bilateral |
5 (12.5) |
10 (90.9) |
|
EBERs
expression |
0.0111 |
||
+ |
19 (47.5) |
0 |
|
- |
21 (52.5) |
11 (100) |
|
EBER:
Epstein-Barr virus-encoded small RNA; IOIP: Idiopathic orbital inflammatory
pseudotumor; TAO: Thyroid-associated ophthalmopathy.1Pearson’s Chi-squared
test with Yates’ continuity correction; 2Independent samples t-test.
Epstein-Barr
Virus-encoded Small RNA-positive Cells in Idiopathic Orbital Inflammatory
Pseudotumor In situ
hybridization revealed that the EBER-positive cells in IOIP tissues could be
divided into two subtypes. The first category was lymphocytes, which included
small-medium-sized lymphocytes and activated immunoblasts. Observation of the
continuous sections after Immunohistochemical staining revealed that some of
these cells were CD20+ B lymphocytes, although most of them could
not be confirmed to express CD3 or CD20. The EBER-positive cells were mainly
distributed in medium-small lymphocytes around follicles and in the nuclei of
activated immunoblasts. In addition, three samples revealed that several
ectopic folliculargerminal centers harbored 2-8 EBER-positive centroblasts. The
second category included the spindle cells that proliferated in interstitial
lesions and differentiated into fibroblasts/myofibroblasts. In total, three
specimens with EBER-positive lymphocytes as well as EBER expression in the
nuclei of mesenchymal spindle cells were observed (Figure 1). The density and
distribution of EBER-positive cells in the 19 specimens are listed in Table 2.
In contrast, in situ hybridization revealed that the inflammatory cells
and spindle cells that infiltrated into extraocular muscle and caused
hyperplasia were both EBER negative (Figure 2).
Figure
1 In situ hybridization revealed positive EBER expression in the
following cells or locations A:
Medium-small lymphocytes in IOIP tissues (×400); B: Medium-small lymphocytes in
IOIP tissues as well as the nuclei of immunoblasts (×400); C: The nuclei of
CD20+ B immunoblasts (×200); D: The nuclei of activated immunoblasts
(×400); E: Centroblasts in the germinal centers of ectopic lymphoid follicles
as well as lymphocytes around the follicles (in nuclei) (×200); F: Nuclei of
mesenchymal spindle cells and lymphocytes (×400).
Figure
2 In situ hybridization revealed negative EBER expression in orbital
tissues of the extraocular muscles of TAO patients A: Inflammatory cells and spindle cells
(×200); B: Adipose hyperplasia (×200).
Table
2 The density and distribution of EBER-positive cells in IOIP specimens
Case No. |
Gender |
Age (a) |
Laterality |
Pathological
type |
EBERs+
cells/section |
Type and
distribution of EBER+ cells |
1 |
Female |
41 |
Right |
Lymphocyte
dominant |
25 |
Inter-follicular
small lymphocytes and immunoblasts |
2 |
Male |
39 |
Right |
Lymphocyte
dominant |
80-100 |
Inter-follicular
medium-small lymphocytes and immunoblasts |
3 |
Male |
32 |
Right |
Lymphocyte
dominant |
5 |
Inter-follicular
immunoblasts |
4 |
Female |
53 |
Right |
Mixed |
2 |
Inter-follicular
immunoblasts |
5 |
Male |
35 |
Right |
Lymphocyte
dominant |
>200 |
Inter-follicular
small lymphocytes, medium-sized lymphocytes, and large immunoblasts,
mesenchymal spindle cells, 8 positive centroblasts in 1 germinal center. |
6 |
Female |
39 |
Bilateral |
Lymphocyte
dominant |
4 |
Inter-follicular
small lymphocytes and immunoblasts |
7 |
Female |
70 |
Right |
Lymphocyte
dominant |
7 |
Inter-follicular
small lymphocytes and immunoblasts |
8 |
Female |
38 |
Bilateral |
Lymphocyte
dominant |
2 |
Inter-follicular
immunoblasts |
9 |
Male |
64 |
Bilateral |
Lymphocyte
dominant |
>200 |
Inter-follicular
small lymphocytes, immunoblasts, karyotypic irregular medium-sized
lymphocytes and immunoblasts, mesenchymal spindle cells, 1-2 positive
centroblasts in 2 germinal centers |
10 |
Female |
65 |
Left |
Lymphocyte
dominant |
3 |
Inter-follicular
small lymphocytes and immunoblasts |
11 |
Female |
60 |
Right |
Lymphocyte
dominant |
2 |
Inter-follicular
small lymphocytes and immunoblasts |
12 |
Female |
67 |
Right |
Lymphocyte
dominant |
20 |
Inter-follicular
small lymphocytes and immunoblasts |
13 |
Male |
35 |
Bilateral |
Lymphocyte
dominant |
15 |
Inter-follicular
small lymphocytes and immunoblasts |
14 |
Female |
68 |
Left |
Mixed |
12 |
Inter-follicular
small lymphocytes and immunoblasts |
15 |
Female |
55 |
Left |
Fibrous |
5 |
Small
lymphocytes |
16 |
Male |
69 |
Right |
Mixed |
11 |
Immunoblasts |
17 |
Female |
76 |
Left |
Mixed |
>200 |
Small
lymphocytes, medium-sized lymphocytes, immunoblasts, and inside the nuclei of
mesenchymal spindle cells |
18 |
Female |
84 |
Right |
Mixed |
40 |
Medium-small
lymphocytes and immunoblasts |
19 |
Male |
56 |
Right |
Mixed |
6 |
Small
lymphocytes |
EBER:
Epstein-Barr virus-encoded small RNA; IOIP: Idiopathic orbital inflammatory
pseudotumor.
DISCUSSION
Using
in situ hybridization, we found that IOIP tissues exhibited a total EBER-positive
rate of 47.5% (19/40), resulting from latent, high-frequency infection by EBV.
The cell types of the EBER-positive population mainly included
small-medium-sized lymphocytes and activated immunoblasts, although several
specimens also exhibited ectopic folliculargerminal centers with EBER-positive
centroblasts as well as spindle cells, which proliferated in interstitial
lesions and differentiated into fibroblasts/myofibroblasts. The EBER-positive
cells were mainly distributed between ectopic folliculargerminal centers and
lymphocytes around follicles or disseminated in infiltrated lymphocytes.
Because EBER-induced activation of the innate immune system may cause
immunopathological diseases associated with EBV infection[13,16-17], our data further revealed that
EBERs are closely related to IOIP pathogenesis.
In
the lesions, ectopic lymphoid tissues emerged in the germinal centers of
B-lymphatic follicles, and the follicles exhibited irregular enlargement. Among
the 21 cases in which lymphocytes were the main EBER-positive population, 18
showed development of ectopic follicular germinal centers. In addition, in the
11 specimens with a mixed subtype, three manifested similar morphological
changes. These findings indicated that autoreactive B cells exhibited specific
clonal expansion in response to antigens in target organs. These lymphatic
tissues may therefore become acquired lymphoid tissue under conditions of EBV
infection and abnormal autoimmunity and continuously proliferate upon
stimulation by antigens. The morphological changes in the IOIP lesions are
consistent with the autoimmunity theory by Pender[18]
regarding autoreactive B cells resulting from EBV infection. Specifically, the
T cells resulting from local EBV infection repeatedly attack target organs,
thereby generating ectopic lymphatic follicles with germinal centers in target
organs. As a consequence, a large quantity of autoreactive B cells are
produced, which may be the underlying cause of autoimmune diseases after EBV
infection. Hence, Dreyfus[19] proposed a
potentially effective anti-viral approach by employing virus-targeting drugs
such as rituximab, which depletes memory B cells, or acyclovir, which is an
anti-retroviral integrase inhibitor.
A
previous study demonstrated that nine IOIP plasma specimens with different
histological traits exhibited high levels of EBV DNA, although the data did not
elucidate the types and distribution of EBV-infected EBER-positive cells[11]. Yan et al[20]
used in situ hybridization to examine 37 IOIP specimens of the lymphatic
infiltration subtype and found no hybridization signal using EBER mRNA. The
author suggested that EBV possibly only played a role in the initiation of
IOIP; once the tumor forms, the lymphocytes gradually lose genomic fragments or
the entire genome of EBV, resulting the absence of EBERs in the lesion.
Moreover, prolonged preservation of paraffin specimens may also cause loss of
the EBER signal. Here, we used a standardized method for the preservation of
paraffin specimens, and from morphological and molecular perspectives, we
revealed that two major cell components of IOIP lesions, namely lymphocytes and
spindle cells, both harbored EBERs, which are the transcripts of EBV (latent
infection). This finding was complementary to previous IOIP pathological
studies, which have not histologically shown the types and distributions of
EBV-infected cells.
Due
to limitations of the research conditions, we did not use double-labeling for in
situ hybridization or immunochemistry to classify EBER-positive lymphocytes
in IOIP lesions, although such a method might not necessarily facilitate
complete differentiation between different types of EBER-positive cells.
Niedobitek et al[17] reported that
double-labeling of in situ hybridization and immunochemistry were used
to detect non-neoplastic lymphoid tissues and revealed that most EBER-positive
cells in the lesions could not be identified via B-cell- or
T-cell-specific antibodies. Another limitation was that the number of male and
females subjects in the TAO group was different because male subjects often had
more severe ocular symptoms than females and required orbital decompression.
In
summary, this study used histological and morphological approaches to
demonstrate that high-level EBER expression was present in the IOIP lesions of
humans. Furthermore, our data revealed the types, distributions, and locations
of EBER-positive cells. These findings are conducive for a better understanding
of the underlying mechanisms of EBV infection in IOIP pathogenesis.
Nonetheless, it remains to be determined whether the presence of EBERs
indicates that IOIP patients are in the early stage of EBV reactivation.
ACKNOWLEDGEMENTS
Foundations:
Supported by the National Natural Science Foundation of China
(No.81260149; No.81360152; No.81560162); Guangxi Natural Science Foundation
(No.2016GXNSFAA380301); Youth Science Foundation of Guangxi Medical University
(No.GXMUYSF2014040).
Conflicts of Interest: Ren MW, None; Du
Y, None; Ren S, None; Tang CY, None; He JF, None.
REFERENCES
1 Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital
pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol 2008;15(1):17-27. [CrossRef]
[PMC free article] [PubMed]
2 Shen T, Chen J, Lin J, Liu R, Yan J. Concomitant
idiopathic orbital inflammatory pseudotumor and thyroid-associated ophthalmopathy.
J Craniofac Surg
2015;26(6):e479-e481. [CrossRef]
[PubMed]
3 Xu X, Du Y, Ding Y, Ye H, Yang H. Idiopathic orbital
inflammation associated with panuveitis in an adult and a review of the
literature. Eye Sci 2013;28(1):40-43.
[PubMed]
4 Shields JA, Shields CL. Orbital pseudotumor versus
idiopathic nongranulomatous orbital inflammation. Ophthal Plast Reconstr Surg 2013;29(5):349. [CrossRef]
[PubMed]
5 Li J, Ge X, Ma JM. Relationship between dacryoadenitis
subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis.
Int J Ophthalmol 2016;9(3):444-447. [PMC free article] [PubMed]
6 Bergmann KR, Schloff S, Schiff J. Contralateral
recurrence of idiopathic orbital inflammatory syndrome in a pediatric patient. Minn Med 2014;97(10):46-47. [PubMed]
7 Yuen SJ, Rubin PA. Idiopathic orbital inflammation:
ocular mechanisms and clinicopathology. Ophthalmol
Clin North Am 2002;15(1):121-126. [CrossRef]
8 Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C,
Lubner M, Menias CO. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol
2012;198(3):W217-W227. [CrossRef] [PubMed]
9 Pender MP. Infection of autoreactive B
lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24(11):584-588. [CrossRef]
10 Bijlsma WR, Kalmann R, Dekkers J, Paridaens D, Mourits
MP, Kloos R, de Groot-Mijnes JD. Identification of infectious entities in
idiopathic orbital inflammation biopsies. Br
J Ophthalmol 2013;97(5):664-665. [CrossRef]
[PubMed]
11 Jin R, Zhao P, Ma X, Ma J, Wu Y, Yang X, Zhang J,
Zhong R, Zeng Y. Quantification of Epstein-Barr virus DNA in patients with
idiopathic orbital inflammatory pseudotumor. PLoS One 2013;8(1):e50812. [CrossRef]
[PMC free article] [PubMed]
12 Gulley ML. Molecular diagnosis of Epstein-Barr
virus-related diseases. J Mol Diagn
2001;3(1):1-10. [CrossRef]
13 Ahmed W, Philip PS, Tariq S, Khan G. Epstein-Barr
virus-encoded small RNAs (EBERs) are present in fractions related to exosomes
released by EBV-transformed cells. PLoS
One 2014;9(6):e99163. [CrossRef]
[PMC free article] [PubMed]
14 Henderson JW. Orbital tumors. 3rd ed: Raven Press;
1994:391-411.
15 Bartley GB, Gorman CA. Diagnostic criteria for
Graves' ophthalmopathy. Am J Ophthalmol
1995;119(6):792-795. [CrossRef]
16 Olson JK, Croxford JL, Miller SD. Virus-induced
autoimmunity: potential role of viruses in initiation, perpetuation, and
progression of T-cell-mediated autoimmune disease. Viral Immunol 2001;14(3):227-250. [CrossRef]
[PubMed]
17 Niedobitek G, Herbst H, Young LS, Brooks L, Masucci
MG, Crocker J, Rickinson AB, Stein H. Patterns of Epstein-Barr virus infection
in non-neoplastic lymphoid tissue. Blood 1992;79(10):2520-2526.
[PubMed]
18 Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr
virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying
hypothesis. Autoimmune Dis
2012;2012:189096. [CrossRef]
19 Dreyfus DH. Autoimmune disease: A role for new
anti-viral therapies? Autoimmun Rev
2011;11(2):88-97. [CrossRef]
[PubMed]